Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (FRA:08HH)

Market Cap	7.99B +6.7%
Revenue (ttm)	4.73B -5.0%
Net Income	392.98M +55.3%
EPS	0.15 +57.6%
Shares Out	n/a
PE Ratio	20.34
Forward PE	n/a
Dividend	0.04 (1.75%)
Ex-Dividend Date	Jul 24, 2025

Volume	1,100
Average Volume	79
Open	2.174
Previous Close	2.168
Day's Range	2.174 - 2.174
52-Week Range	1.484 - 3.220
Beta	n/a
RSI	46.39
Earnings Date	Mar 25, 2026

About FRA:08HH

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 40,557
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 08HH

Financial Performance

In 2024, FRA:08HH's revenue was 41.07 billion, a decrease of -0.80% compared to the previous year's 41.40 billion. Earnings were 2.77 billion, an increase of 16.13%.

Financial numbers in CNY